TH-Z93

CAS No. 2260887-09-8

TH-Z93( —— )

Catalog No. M36537 CAS No. 2260887-09-8

TH-Z93 is a potent FPPS inhibitor (IC50:90 nM) and a lipophilic bisphosphonate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 297 In Stock
10MG 432 In Stock
25MG 655 In Stock
50MG 886 In Stock
100MG 1190 In Stock
200MG Get Quote In Stock
500MG 2390 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TH-Z93
  • Note
    Research use only, not for human use.
  • Brief Description
    TH-Z93 is a potent FPPS inhibitor (IC50:90 nM) and a lipophilic bisphosphonate.
  • Description
    TH-Z93, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 90 nM).
  • In Vitro
    ——
  • In Vivo
    TH-Z93 (20 μg, i.p.) exhibits strong prophylactic effects in a pathogenic influenza model.Animal Model:B16-OVA cells (s.c.) xenograft mice model.Dosage:20 μg Administration:Intraperitoneal injection (i.p.)Result:Inhibited tumor growth and prolonged survival.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2260887-09-8
  • Formula Weight
    368.26
  • Molecular Formula
    C12H22N2O7P2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 1.89 mg/mL (5.13 mM; ultrasonic and warming and adjust pH to 10 with NaOH and heat to 60°C)
  • SMILES
    C(NC1=CC(OCCCCCC)=CC=N1)(P(=O)(O)O)P(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xia Y, et al. The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery. Cell. 2018 Nov 1;175(4):1059-1073.e21. ?
molnova catalog
related products
  • GSK-1322322

    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.

  • MtUng-IN-1

    MtUng-IN-1 (Compound 18a) inhibits mycobacterial uracil DNA glycosylase (MtUng) with an IC50 value of 300 μM and is suitable for cancer and infectious disease research.

  • SR 1078

    SR1078 is an agonist of retinoic acid receptor-related orphan receptor (ROR)α/γ.